🇺🇸 FDA
Pipeline program

SINECATECHINS

SINECHSIL

Approved small_molecule active

Quick answer

SINECATECHINS for Anal high-grade squamous intraepithelial lesions (HSIL). is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Anal high-grade squamous intraepithelial lesions (HSIL).
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials